English

ARONEX PHARMACEUTICALS INC

EDGAR

Quarterly report (10-Q) · filed 2001-05-15

23 filing records in this dataset, filed from 1996-05-15 to 2001-05-15. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest fiscal year

Revenue

3.22 million USD

2000 · USD

Exact inputs and evidence

Revenue: 3219000 USD Source

Operating margin

-516.71%

2000 · %

Exact inputs and evidence

Operating Income: -16633000 USD Source
Revenue: 3219000 USD Source

Operating cash flow

-18.3 million USD

2000 · USD

Exact inputs and evidence

Operating Cash Flow: -18267000 USD Source

Free cash flow

-18.7 million USD

2000 · USD

Exact inputs and evidence

Operating Cash Flow: -18267000 USD Source
Capital Expenditure: 401000 USD Source

Cash and cash equivalents: 4.49 million USD 2000-12-31 Source
Exact value

4485000 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2001-05-15.

Financial data available through: 2000-12-31.

Coverage by financial measure

Revenue: 7 of 11 periods available· newest 2000-12-31
Operating income: 3 of 11 periods available· newest 2000-12-31
Net income: 7 of 11 periods available· newest 2000-12-31
Operating cash flow: 6 of 11 periods available· newest 2000-12-31
Capital expenditure: 6 of 11 periods available· newest 2000-12-31
Total assets: 6 of 11 periods available· newest 2000-12-31
liabilities: No compatible figures in this window
Current assets: 6 of 11 periods available· newest 2000-12-31
Current liabilities: 6 of 11 periods available· newest 2000-12-31
Cash and cash equivalents: 7 of 11 periods available· newest 2000-12-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
-70.9%

Prior period

USD 11.05 million

1999-01-01 – 1999-12-31
Current period

USD 3.22 million

2000-01-01 – 2000-12-31

Exact inputs and evidence

3219000 − 11052000 = -7833000 USD

11052000 USD · 1999-01-01 – 1999-12-31
Inspect prior input Prior source
3219000 USD · 2000-01-01 – 2000-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · ARONEX PHARMACEUTICALS INC · 2000-12-31 ARONEX PHARMACEUTICALS INC (edgar:854691) Year-over-year change in Revenue: -7833000 USD Concept: fundies:Revenue Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T09:16:12Z Snapshot: a900f235bbb54ac260ebf9d6ea0eace5566b9a2d3c623fd832677d62d4039583 Dimensions: Consolidated View: https://fundies.io/companies/edgar/854691?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 3219000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/854691/0000950129-01-001852.txt#3171 Input fundies:Revenue: 11052000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/854691/0000950129-01-001852.txt#3171
The citation records this snapshot. The page link may show a newer release later.
Net income
−USD 3.86 million

Prior period

−USD 14.09 million

1999-01-01 – 1999-12-31
Current period

−USD 17.96 million

2000-01-01 – 2000-12-31

Exact inputs and evidence

-17957000 − -14094000 = -3863000 USD

-14094000 USD · 1999-01-01 – 1999-12-31
Inspect prior input Prior source
-17957000 USD · 2000-01-01 – 2000-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · ARONEX PHARMACEUTICALS INC · 2000-12-31 ARONEX PHARMACEUTICALS INC (edgar:854691) Year-over-year change in Net income: -3863000 USD Concept: fundies:NetIncome Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T09:16:12Z Snapshot: a900f235bbb54ac260ebf9d6ea0eace5566b9a2d3c623fd832677d62d4039583 Dimensions: Consolidated View: https://fundies.io/companies/edgar/854691?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -17957000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/854691/0000950129-01-001852.txt#3963 Input fundies:NetIncome: -14094000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/854691/0000950129-01-001852.txt#3963
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 5.18 million

Prior period

−USD 13.09 million

1999-01-01 – 1999-12-31
Current period

−USD 18.27 million

2000-01-01 – 2000-12-31

Exact inputs and evidence

-18267000 − -13087000 = -5180000 USD

-13087000 USD · 1999-01-01 – 1999-12-31
Inspect prior input Prior source
-18267000 USD · 2000-01-01 – 2000-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · ARONEX PHARMACEUTICALS INC · 2000-12-31 ARONEX PHARMACEUTICALS INC (edgar:854691) Year-over-year change in Operating cash flow: -5180000 USD Concept: fundies:OperatingCashFlow Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T09:16:12Z Snapshot: a900f235bbb54ac260ebf9d6ea0eace5566b9a2d3c623fd832677d62d4039583 Dimensions: Consolidated View: https://fundies.io/companies/edgar/854691?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -18267000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/854691/0000950129-01-001852.txt#3985 Input fundies:OperatingCashFlow: -13087000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/854691/0000950129-01-001852.txt#3985
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+6.4%

Prior period

USD 377,000

1999-01-01 – 1999-12-31
Current period

USD 401,000

2000-01-01 – 2000-12-31

Exact inputs and evidence

401000 − 377000 = 24000 USD

377000 USD · 1999-01-01 – 1999-12-31
Inspect prior input Prior source
401000 USD · 2000-01-01 – 2000-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · ARONEX PHARMACEUTICALS INC · 2000-12-31 ARONEX PHARMACEUTICALS INC (edgar:854691) Year-over-year change in Capital expenditure: 24000 USD Concept: fundies:CapitalExpenditure Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T09:16:12Z Snapshot: a900f235bbb54ac260ebf9d6ea0eace5566b9a2d3c623fd832677d62d4039583 Dimensions: Consolidated View: https://fundies.io/companies/edgar/854691?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 401000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/854691/0000950129-01-001852.txt#3991 Input fundies:CapitalExpenditure: 377000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/854691/0000950129-01-001852.txt#3991
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2000 2000-01-01 – 2000-12-31

Revenue USD 3.22 million 100% of revenue
Operating costs Derived USD 19.85 million 617% of revenue
Operating income −USD 16.63 million −517% of revenue
Tax, interest and other Derived USD 1.32 million 41% of revenue
Net income −USD 17.96 million −558% of revenue

Cash

Operating cash flow −USD 18.27 million −567% of revenue
Capital expenditure USD 401,000 12% of revenue
Free cash flow Derived −USD 18.67 million −580% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

1994 Not shown: operating income or net income is not reported.
1995 Not shown: operating income or net income is not reported.
1996 Not shown: operating income or net income is not reported.
1997 Not shown: operating income or net income is not reported.
1998 Operating loss: operating costs were 388% of revenue.
1999 Operating loss: operating costs were 237% of revenue.
2000 Operating loss: operating costs were 617% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
1994 1994-01-01 – 1994-12-31	731000	Unavailable	Unavailable	Unavailable	-9052000	Unavailable	Source 1994-01-01 – 1994-12-31: 731000 USD Inspect Revenue Open source 1994-01-01 – 1994-12-31: -9052000 USD Inspect Net Income Open source
1995 1995-01-01 – 1995-12-31	1700000	Unavailable	Unavailable	Unavailable	-17429000	-6671000 Derived	Source 1995-01-01 – 1995-12-31: 1700000 USD Inspect Revenue Open source 1995-01-01 – 1995-12-31: -17429000 USD Inspect Net Income Open source 1995-01-01 – 1995-12-31: -6534000 USD Inspect Operating Cash Flow Open source 1995-01-01 – 1995-12-31: 137000 USD Inspect Capital Expenditure Open source
1996 1996-01-01 – 1996-12-31	4362000	Unavailable	Unavailable	Unavailable	-8030000	-7848000 Derived	Source 1996-01-01 – 1996-12-31: 4362000 USD Inspect Revenue Open source 1996-01-01 – 1996-12-31: -8030000 USD Inspect Net Income Open source 1996-01-01 – 1996-12-31: -7592000 USD Inspect Operating Cash Flow Open source 1996-01-01 – 1996-12-31: 256000 USD Inspect Capital Expenditure Open source
1997 1997-01-01 – 1997-12-31	2900000	Unavailable	Unavailable	Unavailable	-16991000	-11041000 Derived	Source 1997-01-01 – 1997-12-31: 2900000 USD Inspect Revenue Open source 1997-01-01 – 1997-12-31: -16991000 USD Inspect Net Income Open source 1997-01-01 – 1997-12-31: -10689000 USD Inspect Operating Cash Flow Open source 1997-01-01 – 1997-12-31: 352000 USD Inspect Capital Expenditure Open source
1998 1998-01-01 – 1998-12-31	6737000	26147000 Derived	-19410000	-1179000 Derived	-18231000	-14163000 Derived	Source 1998-01-01 – 1998-12-31: 6737000 USD Inspect Revenue Open source 1998-01-01 – 1998-12-31: -19410000 USD Inspect Operating Income Open source 1998-01-01 – 1998-12-31: -18231000 USD Inspect Net Income Open source 1998-01-01 – 1998-12-31: -12205000 USD Inspect Operating Cash Flow Open source 1998-01-01 – 1998-12-31: 1958000 USD Inspect Capital Expenditure Open source
1999 1999-01-01 – 1999-12-31	11052000	26146000 Derived	-15094000	-1000000 Derived	-14094000	-13464000 Derived	Source 1999-01-01 – 1999-12-31: 11052000 USD Inspect Revenue Open source 1999-01-01 – 1999-12-31: -15094000 USD Inspect Operating Income Open source 1999-01-01 – 1999-12-31: -14094000 USD Inspect Net Income Open source 1999-01-01 – 1999-12-31: -13087000 USD Inspect Operating Cash Flow Open source 1999-01-01 – 1999-12-31: 377000 USD Inspect Capital Expenditure Open source
2000 2000-01-01 – 2000-12-31	3219000	19852000 Derived	-16633000	1324000 Derived	-17957000	-18668000 Derived	Source 2000-01-01 – 2000-12-31: 3219000 USD Inspect Revenue Open source 2000-01-01 – 2000-12-31: -16633000 USD Inspect Operating Income Open source 2000-01-01 – 2000-12-31: -17957000 USD Inspect Net Income Open source 2000-01-01 – 2000-12-31: -18267000 USD Inspect Operating Cash Flow Open source 2000-01-01 – 2000-12-31: 401000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 3.2M 2000

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
19941994-12-31	Revenue	731000	Revenue: 731000 Open source
19951995-12-31	Revenue	1700000	Revenue: 1700000 Open source
19961996-12-31	Revenue	4362000	Revenue: 4362000 Open source
19971997-12-31	Revenue	2900000	Revenue: 2900000 Open source
19981998-12-31	Revenue	6737000	Revenue: 6737000 Open source
19991999-12-31	Revenue	11052000	Revenue: 11052000 Open source
20002000-12-31	Revenue	3219000	Revenue: 3219000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-70.9% 2000

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
19941994-12-31	Year over year	No prior comparable period	Revenue: 731000 Open source
19951995-12-31	Year over year	132.6%	Revenue: 1700000 Open source Revenue: 731000 Open source
19961996-12-31	Year over year	156.6%	Revenue: 4362000 Open source Revenue: 1700000 Open source
19971997-12-31	Year over year	-33.5%	Revenue: 2900000 Open source Revenue: 4362000 Open source
19981998-12-31	Year over year	132.3%	Revenue: 6737000 Open source Revenue: 2900000 Open source
19991999-12-31	Year over year	64%	Revenue: 11052000 Open source Revenue: 6737000 Open source
20002000-12-31	Year over year	-70.9%	Revenue: 3219000 Open source Revenue: 11052000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -516.7% 2000

Net margin -557.8% 2000

Free cash flow margin -579.9% 2000

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
1994-12-31	Operating margin	Not reported	Revenue: 731000 Open source
1995-12-31	Operating margin	Not reported	Revenue: 1700000 Open source
1996-12-31	Operating margin	Not reported	Revenue: 4362000 Open source
1997-12-31	Operating margin	Not reported	Revenue: 2900000 Open source
19981998-12-31	Operating margin	-288.1%	Operating Income: -19410000 Open source Revenue: 6737000 Open source
19991999-12-31	Operating margin	-136.6%	Operating Income: -15094000 Open source Revenue: 11052000 Open source
20002000-12-31	Operating margin	-516.7%	Operating Income: -16633000 Open source Revenue: 3219000 Open source
19941994-12-31	Net margin	-1,238.3%	Net Income: -9052000 Open source Revenue: 731000 Open source
19951995-12-31	Net margin	-1,025.2%	Net Income: -17429000 Open source Revenue: 1700000 Open source
19961996-12-31	Net margin	-184.1%	Net Income: -8030000 Open source Revenue: 4362000 Open source
19971997-12-31	Net margin	-585.9%	Net Income: -16991000 Open source Revenue: 2900000 Open source
19981998-12-31	Net margin	-270.6%	Net Income: -18231000 Open source Revenue: 6737000 Open source
19991999-12-31	Net margin	-127.5%	Net Income: -14094000 Open source Revenue: 11052000 Open source
20002000-12-31	Net margin	-557.8%	Net Income: -17957000 Open source Revenue: 3219000 Open source
19941994-12-31	Free cash flow margin	Not reported	Revenue: 731000 Open source
19951995-12-31	Free cash flow margin	-392.4%	Revenue: 1700000 Open source Operating Cash Flow: -6534000 Open source Capital Expenditure: 137000 Open source
19961996-12-31	Free cash flow margin	-179.9%	Revenue: 4362000 Open source Operating Cash Flow: -7592000 Open source Capital Expenditure: 256000 Open source
19971997-12-31	Free cash flow margin	-380.7%	Revenue: 2900000 Open source Operating Cash Flow: -10689000 Open source Capital Expenditure: 352000 Open source
19981998-12-31	Free cash flow margin	-210.2%	Revenue: 6737000 Open source Operating Cash Flow: -12205000 Open source Capital Expenditure: 1958000 Open source
19991999-12-31	Free cash flow margin	-121.8%	Revenue: 11052000 Open source Operating Cash Flow: -13087000 Open source Capital Expenditure: 377000 Open source
20002000-12-31	Free cash flow margin	-579.9%	Revenue: 3219000 Open source Operating Cash Flow: -18267000 Open source Capital Expenditure: 401000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -18.3M 2000

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19941994-12-31	Operating cash flow	Not reported	No source recorded
19951995-12-31	Operating cash flow	-6534000	Operating Cash Flow: -6534000 Open source
19961996-12-31	Operating cash flow	-7592000	Operating Cash Flow: -7592000 Open source
19971997-12-31	Operating cash flow	-10689000	Operating Cash Flow: -10689000 Open source
19981998-12-31	Operating cash flow	-12205000	Operating Cash Flow: -12205000 Open source
19991999-12-31	Operating cash flow	-13087000	Operating Cash Flow: -13087000 Open source
20002000-12-31	Operating cash flow	-18267000	Operating Cash Flow: -18267000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -18.7M 2000

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19941994-12-31	Free cash flow	Unavailable	No source recorded
19951995-12-31	Free cash flow	-6671000	Operating Cash Flow: -6534000 Open source Capital Expenditure: 137000 Open source
19961996-12-31	Free cash flow	-7848000	Operating Cash Flow: -7592000 Open source Capital Expenditure: 256000 Open source
19971997-12-31	Free cash flow	-11041000	Operating Cash Flow: -10689000 Open source Capital Expenditure: 352000 Open source
19981998-12-31	Free cash flow	-14163000	Operating Cash Flow: -12205000 Open source Capital Expenditure: 1958000 Open source
19991999-12-31	Free cash flow	-13464000	Operating Cash Flow: -13087000 Open source Capital Expenditure: 377000 Open source
20002000-12-31	Free cash flow	-18668000	Operating Cash Flow: -18267000 Open source Capital Expenditure: 401000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
1994-12-31	Liabilities / assets	Not reported	No source recorded
1995-12-31	Liabilities / assets	Not reported	Total Assets: 15530000 Open source
1996-12-31	Liabilities / assets	Not reported	Total Assets: 44281000 Open source
1997-12-31	Liabilities / assets	Not reported	Total Assets: 32125000 Open source
1998-12-31	Liabilities / assets	Not reported	Total Assets: 23045000 Open source
1999-12-31	Liabilities / assets	Not reported	Total Assets: 22734000 Open source
2000-12-31	Liabilities / assets	Not reported	Total Assets: 7183000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

1.14× 2000

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
1994-12-31	Current assets / current liabilities	Not reported	No source recorded
19951995-12-31	Current assets / current liabilities	5.55×	Current Assets: 10894000 Open source Current Liabilities: 1962000 Open source
19961996-12-31	Current assets / current liabilities	9.66×	Current Assets: 35334000 Open source Current Liabilities: 3658000 Open source
19971997-12-31	Current assets / current liabilities	4.3×	Current Assets: 20386000 Open source Current Liabilities: 4740000 Open source
19981998-12-31	Current assets / current liabilities	2.31×	Current Assets: 19487000 Open source Current Liabilities: 8423000 Open source
19991999-12-31	Current assets / current liabilities	4.41×	Current Assets: 19785000 Open source Current Liabilities: 4486000 Open source
20002000-12-31	Current assets / current liabilities	1.14×	Current Assets: 4731000 Open source Current Liabilities: 4136000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
1994 1994-01-01 – 1994-12-31	−USD 9.05 million Exact value Exact value: -9052000 USD 1994-01-01 – 1994-12-31: -9052000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ARONEX PHARMACEUTICALS INC · 1994-12-31 ARONEX PHARMACEUTICALS INC (edgar:854691) Net Income: -9052000 USD Concept: fundies:NetIncome Period: 1994-01-01 to 1994-12-31 Values: Latest reported Published: 2026-11-02T09:16:12Z Snapshot: a900f235bbb54ac260ebf9d6ea0eace5566b9a2d3c623fd832677d62d4039583 Dimensions: Consolidated View: https://fundies.io/companies/edgar/854691/explain?concept=fundies%3ANetIncome&period=1994-12-31&surface=latest&period_type=duration&start=1994-01-01&unit=USD&dimensions= Input fundies:NetIncome: -9052000 USD (1994-01-01 to 1994-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/854691/0000899243-97-000540.txt#2764 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.
1995 1995-01-01 – 1995-12-31	−USD 17.43 million Exact value Exact value: -17429000 USD 1995-01-01 – 1995-12-31: -17429000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ARONEX PHARMACEUTICALS INC · 1995-12-31 ARONEX PHARMACEUTICALS INC (edgar:854691) Net Income: -17429000 USD Concept: fundies:NetIncome Period: 1995-01-01 to 1995-12-31 Values: Latest reported Published: 2026-11-02T09:16:12Z Snapshot: a900f235bbb54ac260ebf9d6ea0eace5566b9a2d3c623fd832677d62d4039583 Dimensions: Consolidated View: https://fundies.io/companies/edgar/854691/explain?concept=fundies%3ANetIncome&period=1995-12-31&surface=latest&period_type=duration&start=1995-01-01&unit=USD&dimensions= Input fundies:NetIncome: -17429000 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/854691/0000950129-98-001383.txt#3228 The citation records this snapshot. The page link may show a newer release later.	−USD 6.53 million Exact value Exact value: -6534000 USD 1995-01-01 – 1995-12-31: -6534000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ARONEX PHARMACEUTICALS INC · 1995-12-31 ARONEX PHARMACEUTICALS INC (edgar:854691) Operating Cash Flow: -6534000 USD Concept: fundies:OperatingCashFlow Period: 1995-01-01 to 1995-12-31 Values: Latest reported Published: 2026-11-02T09:16:12Z Snapshot: a900f235bbb54ac260ebf9d6ea0eace5566b9a2d3c623fd832677d62d4039583 Dimensions: Consolidated View: https://fundies.io/companies/edgar/854691/explain?concept=fundies%3AOperatingCashFlow&period=1995-12-31&surface=latest&period_type=duration&start=1995-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -6534000 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/854691/0000950129-98-001383.txt#3250 The citation records this snapshot. The page link may show a newer release later.	USD 137,000 Exact value Exact value: 137000 USD 1995-01-01 – 1995-12-31: 137000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ARONEX PHARMACEUTICALS INC · 1995-12-31 ARONEX PHARMACEUTICALS INC (edgar:854691) Capital Expenditure: 137000 USD Concept: fundies:CapitalExpenditure Period: 1995-01-01 to 1995-12-31 Values: Latest reported Published: 2026-11-02T09:16:12Z Snapshot: a900f235bbb54ac260ebf9d6ea0eace5566b9a2d3c623fd832677d62d4039583 Dimensions: Consolidated View: https://fundies.io/companies/edgar/854691/explain?concept=fundies%3ACapitalExpenditure&period=1995-12-31&surface=latest&period_type=duration&start=1995-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 137000 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/854691/0000950129-98-001383.txt#3254 The citation records this snapshot. The page link may show a newer release later.	−USD 6.67 million Calculation and evidence -6534000 − 137000 USD Exact free cash flow: -6671000 USD 1995-01-01 – 1995-12-31: -6534000 USD · Inspect Operating Cash Flow · Source 1995-01-01 – 1995-12-31: 137000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ARONEX PHARMACEUTICALS INC · 1995-12-31 ARONEX PHARMACEUTICALS INC (edgar:854691) Free cash flow: -6671000 USD Concept: free-cash-flow Period: 1995-01-01 to 1995-12-31 Values: Latest reported Published: 2026-11-02T09:16:12Z Snapshot: a900f235bbb54ac260ebf9d6ea0eace5566b9a2d3c623fd832677d62d4039583 Dimensions: Consolidated View: https://fundies.io/companies/edgar/854691?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -6534000 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/854691/0000950129-98-001383.txt#3250 Input fundies:CapitalExpenditure: 137000 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/854691/0000950129-98-001383.txt#3254 The citation records this snapshot. The page link may show a newer release later.
1996 1996-01-01 – 1996-12-31	−USD 8.03 million Exact value Exact value: -8030000 USD 1996-01-01 – 1996-12-31: -8030000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ARONEX PHARMACEUTICALS INC · 1996-12-31 ARONEX PHARMACEUTICALS INC (edgar:854691) Net Income: -8030000 USD Concept: fundies:NetIncome Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-02T09:16:12Z Snapshot: a900f235bbb54ac260ebf9d6ea0eace5566b9a2d3c623fd832677d62d4039583 Dimensions: Consolidated View: https://fundies.io/companies/edgar/854691/explain?concept=fundies%3ANetIncome&period=1996-12-31&surface=latest&period_type=duration&start=1996-01-01&unit=USD&dimensions= Input fundies:NetIncome: -8030000 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/854691/0000950129-99-001216.txt#3910 The citation records this snapshot. The page link may show a newer release later.	−USD 7.59 million Exact value Exact value: -7592000 USD 1996-01-01 – 1996-12-31: -7592000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ARONEX PHARMACEUTICALS INC · 1996-12-31 ARONEX PHARMACEUTICALS INC (edgar:854691) Operating Cash Flow: -7592000 USD Concept: fundies:OperatingCashFlow Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-02T09:16:12Z Snapshot: a900f235bbb54ac260ebf9d6ea0eace5566b9a2d3c623fd832677d62d4039583 Dimensions: Consolidated View: https://fundies.io/companies/edgar/854691/explain?concept=fundies%3AOperatingCashFlow&period=1996-12-31&surface=latest&period_type=duration&start=1996-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -7592000 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/854691/0000950129-99-001216.txt#3931 The citation records this snapshot. The page link may show a newer release later.	USD 256,000 Exact value Exact value: 256000 USD 1996-01-01 – 1996-12-31: 256000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ARONEX PHARMACEUTICALS INC · 1996-12-31 ARONEX PHARMACEUTICALS INC (edgar:854691) Capital Expenditure: 256000 USD Concept: fundies:CapitalExpenditure Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-02T09:16:12Z Snapshot: a900f235bbb54ac260ebf9d6ea0eace5566b9a2d3c623fd832677d62d4039583 Dimensions: Consolidated View: https://fundies.io/companies/edgar/854691/explain?concept=fundies%3ACapitalExpenditure&period=1996-12-31&surface=latest&period_type=duration&start=1996-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 256000 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/854691/0000950129-99-001216.txt#3937 The citation records this snapshot. The page link may show a newer release later.	−USD 7.85 million Calculation and evidence -7592000 − 256000 USD Exact free cash flow: -7848000 USD 1996-01-01 – 1996-12-31: -7592000 USD · Inspect Operating Cash Flow · Source 1996-01-01 – 1996-12-31: 256000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ARONEX PHARMACEUTICALS INC · 1996-12-31 ARONEX PHARMACEUTICALS INC (edgar:854691) Free cash flow: -7848000 USD Concept: free-cash-flow Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-02T09:16:12Z Snapshot: a900f235bbb54ac260ebf9d6ea0eace5566b9a2d3c623fd832677d62d4039583 Dimensions: Consolidated View: https://fundies.io/companies/edgar/854691?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -7592000 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/854691/0000950129-99-001216.txt#3931 Input fundies:CapitalExpenditure: 256000 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/854691/0000950129-99-001216.txt#3937 The citation records this snapshot. The page link may show a newer release later.
1997 1997-01-01 – 1997-12-31	−USD 16.99 million Exact value Exact value: -16991000 USD 1997-01-01 – 1997-12-31: -16991000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ARONEX PHARMACEUTICALS INC · 1997-12-31 ARONEX PHARMACEUTICALS INC (edgar:854691) Net Income: -16991000 USD Concept: fundies:NetIncome Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-02T09:16:12Z Snapshot: a900f235bbb54ac260ebf9d6ea0eace5566b9a2d3c623fd832677d62d4039583 Dimensions: Consolidated View: https://fundies.io/companies/edgar/854691/explain?concept=fundies%3ANetIncome&period=1997-12-31&surface=latest&period_type=duration&start=1997-01-01&unit=USD&dimensions= Input fundies:NetIncome: -16991000 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/854691/0000950129-00-001854.txt#3594 The citation records this snapshot. The page link may show a newer release later.	−USD 10.69 million Exact value Exact value: -10689000 USD 1997-01-01 – 1997-12-31: -10689000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ARONEX PHARMACEUTICALS INC · 1997-12-31 ARONEX PHARMACEUTICALS INC (edgar:854691) Operating Cash Flow: -10689000 USD Concept: fundies:OperatingCashFlow Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-02T09:16:12Z Snapshot: a900f235bbb54ac260ebf9d6ea0eace5566b9a2d3c623fd832677d62d4039583 Dimensions: Consolidated View: https://fundies.io/companies/edgar/854691/explain?concept=fundies%3AOperatingCashFlow&period=1997-12-31&surface=latest&period_type=duration&start=1997-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -10689000 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/854691/0000950129-00-001854.txt#3616 The citation records this snapshot. The page link may show a newer release later.	USD 352,000 Exact value Exact value: 352000 USD 1997-01-01 – 1997-12-31: 352000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ARONEX PHARMACEUTICALS INC · 1997-12-31 ARONEX PHARMACEUTICALS INC (edgar:854691) Capital Expenditure: 352000 USD Concept: fundies:CapitalExpenditure Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-02T09:16:12Z Snapshot: a900f235bbb54ac260ebf9d6ea0eace5566b9a2d3c623fd832677d62d4039583 Dimensions: Consolidated View: https://fundies.io/companies/edgar/854691/explain?concept=fundies%3ACapitalExpenditure&period=1997-12-31&surface=latest&period_type=duration&start=1997-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 352000 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/854691/0000950129-00-001854.txt#3622 The citation records this snapshot. The page link may show a newer release later.	−USD 11.04 million Calculation and evidence -10689000 − 352000 USD Exact free cash flow: -11041000 USD 1997-01-01 – 1997-12-31: -10689000 USD · Inspect Operating Cash Flow · Source 1997-01-01 – 1997-12-31: 352000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ARONEX PHARMACEUTICALS INC · 1997-12-31 ARONEX PHARMACEUTICALS INC (edgar:854691) Free cash flow: -11041000 USD Concept: free-cash-flow Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-02T09:16:12Z Snapshot: a900f235bbb54ac260ebf9d6ea0eace5566b9a2d3c623fd832677d62d4039583 Dimensions: Consolidated View: https://fundies.io/companies/edgar/854691?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -10689000 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/854691/0000950129-00-001854.txt#3616 Input fundies:CapitalExpenditure: 352000 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/854691/0000950129-00-001854.txt#3622 The citation records this snapshot. The page link may show a newer release later.
1998 1998-01-01 – 1998-12-31	−USD 18.23 million Exact value Exact value: -18231000 USD 1998-01-01 – 1998-12-31: -18231000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ARONEX PHARMACEUTICALS INC · 1998-12-31 ARONEX PHARMACEUTICALS INC (edgar:854691) Net Income: -18231000 USD Concept: fundies:NetIncome Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T09:16:12Z Snapshot: a900f235bbb54ac260ebf9d6ea0eace5566b9a2d3c623fd832677d62d4039583 Dimensions: Consolidated View: https://fundies.io/companies/edgar/854691/explain?concept=fundies%3ANetIncome&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:NetIncome: -18231000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/854691/0000950129-01-001852.txt#3963 The citation records this snapshot. The page link may show a newer release later.	−USD 12.21 million Exact value Exact value: -12205000 USD 1998-01-01 – 1998-12-31: -12205000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ARONEX PHARMACEUTICALS INC · 1998-12-31 ARONEX PHARMACEUTICALS INC (edgar:854691) Operating Cash Flow: -12205000 USD Concept: fundies:OperatingCashFlow Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T09:16:12Z Snapshot: a900f235bbb54ac260ebf9d6ea0eace5566b9a2d3c623fd832677d62d4039583 Dimensions: Consolidated View: https://fundies.io/companies/edgar/854691/explain?concept=fundies%3AOperatingCashFlow&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -12205000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/854691/0000950129-01-001852.txt#3985 The citation records this snapshot. The page link may show a newer release later.	USD 1.96 million Exact value Exact value: 1958000 USD 1998-01-01 – 1998-12-31: 1958000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ARONEX PHARMACEUTICALS INC · 1998-12-31 ARONEX PHARMACEUTICALS INC (edgar:854691) Capital Expenditure: 1958000 USD Concept: fundies:CapitalExpenditure Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T09:16:12Z Snapshot: a900f235bbb54ac260ebf9d6ea0eace5566b9a2d3c623fd832677d62d4039583 Dimensions: Consolidated View: https://fundies.io/companies/edgar/854691/explain?concept=fundies%3ACapitalExpenditure&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1958000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/854691/0000950129-01-001852.txt#3991 The citation records this snapshot. The page link may show a newer release later.	−USD 14.16 million Calculation and evidence -12205000 − 1958000 USD Exact free cash flow: -14163000 USD 1998-01-01 – 1998-12-31: -12205000 USD · Inspect Operating Cash Flow · Source 1998-01-01 – 1998-12-31: 1958000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ARONEX PHARMACEUTICALS INC · 1998-12-31 ARONEX PHARMACEUTICALS INC (edgar:854691) Free cash flow: -14163000 USD Concept: free-cash-flow Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T09:16:12Z Snapshot: a900f235bbb54ac260ebf9d6ea0eace5566b9a2d3c623fd832677d62d4039583 Dimensions: Consolidated View: https://fundies.io/companies/edgar/854691?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -12205000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/854691/0000950129-01-001852.txt#3985 Input fundies:CapitalExpenditure: 1958000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/854691/0000950129-01-001852.txt#3991 The citation records this snapshot. The page link may show a newer release later.
1999 1999-01-01 – 1999-12-31	−USD 14.09 million Exact value Exact value: -14094000 USD 1999-01-01 – 1999-12-31: -14094000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ARONEX PHARMACEUTICALS INC · 1999-12-31 ARONEX PHARMACEUTICALS INC (edgar:854691) Net Income: -14094000 USD Concept: fundies:NetIncome Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T09:16:12Z Snapshot: a900f235bbb54ac260ebf9d6ea0eace5566b9a2d3c623fd832677d62d4039583 Dimensions: Consolidated View: https://fundies.io/companies/edgar/854691/explain?concept=fundies%3ANetIncome&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:NetIncome: -14094000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/854691/0000950129-01-001852.txt#3963 The citation records this snapshot. The page link may show a newer release later.	−USD 13.09 million Exact value Exact value: -13087000 USD 1999-01-01 – 1999-12-31: -13087000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ARONEX PHARMACEUTICALS INC · 1999-12-31 ARONEX PHARMACEUTICALS INC (edgar:854691) Operating Cash Flow: -13087000 USD Concept: fundies:OperatingCashFlow Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T09:16:12Z Snapshot: a900f235bbb54ac260ebf9d6ea0eace5566b9a2d3c623fd832677d62d4039583 Dimensions: Consolidated View: https://fundies.io/companies/edgar/854691/explain?concept=fundies%3AOperatingCashFlow&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -13087000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/854691/0000950129-01-001852.txt#3985 The citation records this snapshot. The page link may show a newer release later.	USD 377,000 Exact value Exact value: 377000 USD 1999-01-01 – 1999-12-31: 377000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ARONEX PHARMACEUTICALS INC · 1999-12-31 ARONEX PHARMACEUTICALS INC (edgar:854691) Capital Expenditure: 377000 USD Concept: fundies:CapitalExpenditure Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T09:16:12Z Snapshot: a900f235bbb54ac260ebf9d6ea0eace5566b9a2d3c623fd832677d62d4039583 Dimensions: Consolidated View: https://fundies.io/companies/edgar/854691/explain?concept=fundies%3ACapitalExpenditure&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 377000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/854691/0000950129-01-001852.txt#3991 The citation records this snapshot. The page link may show a newer release later.	−USD 13.46 million Calculation and evidence -13087000 − 377000 USD Exact free cash flow: -13464000 USD 1999-01-01 – 1999-12-31: -13087000 USD · Inspect Operating Cash Flow · Source 1999-01-01 – 1999-12-31: 377000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ARONEX PHARMACEUTICALS INC · 1999-12-31 ARONEX PHARMACEUTICALS INC (edgar:854691) Free cash flow: -13464000 USD Concept: free-cash-flow Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T09:16:12Z Snapshot: a900f235bbb54ac260ebf9d6ea0eace5566b9a2d3c623fd832677d62d4039583 Dimensions: Consolidated View: https://fundies.io/companies/edgar/854691?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -13087000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/854691/0000950129-01-001852.txt#3985 Input fundies:CapitalExpenditure: 377000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/854691/0000950129-01-001852.txt#3991 The citation records this snapshot. The page link may show a newer release later.
2000 2000-01-01 – 2000-12-31	−USD 17.96 million Exact value Exact value: -17957000 USD 2000-01-01 – 2000-12-31: -17957000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ARONEX PHARMACEUTICALS INC · 2000-12-31 ARONEX PHARMACEUTICALS INC (edgar:854691) Net Income: -17957000 USD Concept: fundies:NetIncome Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T09:16:12Z Snapshot: a900f235bbb54ac260ebf9d6ea0eace5566b9a2d3c623fd832677d62d4039583 Dimensions: Consolidated View: https://fundies.io/companies/edgar/854691/explain?concept=fundies%3ANetIncome&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:NetIncome: -17957000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/854691/0000950129-01-001852.txt#3963 The citation records this snapshot. The page link may show a newer release later.	−USD 18.27 million Exact value Exact value: -18267000 USD 2000-01-01 – 2000-12-31: -18267000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ARONEX PHARMACEUTICALS INC · 2000-12-31 ARONEX PHARMACEUTICALS INC (edgar:854691) Operating Cash Flow: -18267000 USD Concept: fundies:OperatingCashFlow Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T09:16:12Z Snapshot: a900f235bbb54ac260ebf9d6ea0eace5566b9a2d3c623fd832677d62d4039583 Dimensions: Consolidated View: https://fundies.io/companies/edgar/854691/explain?concept=fundies%3AOperatingCashFlow&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -18267000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/854691/0000950129-01-001852.txt#3985 The citation records this snapshot. The page link may show a newer release later.	USD 401,000 Exact value Exact value: 401000 USD 2000-01-01 – 2000-12-31: 401000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ARONEX PHARMACEUTICALS INC · 2000-12-31 ARONEX PHARMACEUTICALS INC (edgar:854691) Capital Expenditure: 401000 USD Concept: fundies:CapitalExpenditure Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T09:16:12Z Snapshot: a900f235bbb54ac260ebf9d6ea0eace5566b9a2d3c623fd832677d62d4039583 Dimensions: Consolidated View: https://fundies.io/companies/edgar/854691/explain?concept=fundies%3ACapitalExpenditure&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 401000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/854691/0000950129-01-001852.txt#3991 The citation records this snapshot. The page link may show a newer release later.	−USD 18.67 million Calculation and evidence -18267000 − 401000 USD Exact free cash flow: -18668000 USD 2000-01-01 – 2000-12-31: -18267000 USD · Inspect Operating Cash Flow · Source 2000-01-01 – 2000-12-31: 401000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ARONEX PHARMACEUTICALS INC · 2000-12-31 ARONEX PHARMACEUTICALS INC (edgar:854691) Free cash flow: -18668000 USD Concept: free-cash-flow Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T09:16:12Z Snapshot: a900f235bbb54ac260ebf9d6ea0eace5566b9a2d3c623fd832677d62d4039583 Dimensions: Consolidated View: https://fundies.io/companies/edgar/854691?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -18267000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/854691/0000950129-01-001852.txt#3985 Input fundies:CapitalExpenditure: 401000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/854691/0000950129-01-001852.txt#3991 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

23 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0000854691, 854691, edgar:854691

ARONEX PHARMACEUTICALS INC

Latest fiscal year

Revenue

Operating margin

Operating cash flow

Free cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2000 2000-01-01 – 2000-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation